Trial Profile
Study the diffusion kinetics of gadolinium at the perilymph of the inner ear structures to patients Meniere's disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2020
Price :
$35
*
At a glance
- Drugs Gadoterate-meglumine (Primary)
- Indications Meniere's disease
- Focus Pharmacokinetics
- Acronyms PROSPER
- 10 Nov 2020 Status changed from recruiting to discontinued.
- 26 Apr 2016 New trial record